LCML
TLSI icon

Lionhunter Capital Management, LLC’s TriSalus Life Sciences TLSI Stock Holding History

Lionhunter Capital Management, LLC’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
+300,275
New +$1.19M 0.62% 45

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Lionhunter Capital Management, LLC's TLSI Position: Q2 2026 in Review

Lionhunter Capital Management, LLC opened a new position in TriSalus Life Sciences (TLSI) in Q2 2026: 300,275 shares worth $1.37M. The stake represents 0.62% of the portfolio and ranks #45 among its holdings.

55 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Lionhunter Capital Management, LLC held 300,275 shares of TriSalus Life Sciences worth $1.37M as of Q2 2026.
  • TriSalus Life Sciences was a new Lionhunter Capital Management, LLC position in Q2 2026.
  • TriSalus Life Sciences made up 0.62% of Lionhunter Capital Management, LLC's portfolio in Q2 2026, its #45 holding.
  • 55 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Lionhunter Capital Management, LLC's 13F filing for Q2 2026, filed 13 Aug 2026.